APYX icon

Apyx Medical

37 hedge funds and large institutions have $33M invested in Apyx Medical in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,044% more capital inflows, than outflows

Capital inflows: $5.62M | Capital outflows: $262K

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

37% more funds holding

Funds holding: 27 → 37 (+10)

5.84% more ownership

Funds ownership: 17.45% → 23.29% (+5.8%)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
37
Holders Change
+10
Holders Change %
+37.04%
% of All Funds
0.98%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
8
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

APYX Hedge Fund Activity: Q3 2016 in Review

37 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2016, worth a combined $33M — up 326% from $7.74M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new APYX positions and 3 closed out — a net gain of 11 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Cortina Asset Management, opening a new position worth an estimated $1.66M. The largest seller was Wasatch Advisors, cutting an estimated $130K.

  • 37 institutional investors held Apyx Medical (APYX) as of Q3 2016, up from 27 in Q2 2016.
  • Funds reported $33M of Apyx Medical stock for Q3 2016, up 326% quarter-over-quarter.
  • 14 funds opened new Apyx Medical positions in Q3 2016 and 3 closed out, a net change of +11 holders.
  • The largest Apyx Medical buyer in Q3 2016 was Cortina Asset Management, an estimated $1.66M added.
  • The largest Apyx Medical seller in Q3 2016 was Wasatch Advisors, an estimated $130K sold.

Based on aggregated 13F filings for Q3 2016.